208 related articles for article (PubMed ID: 23251633)
1. Hexachlorophene is a potent KCNQ1/KCNE1 potassium channel activator which rescues LQTs mutants.
Zheng Y; Zhu X; Zhou P; Lan X; Xu H; Li M; Gao Z
PLoS One; 2012; 7(12):e51820. PubMed ID: 23251633
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome.
Hoosien M; Ahearn ME; Myerburg RJ; Pham TV; Miller TE; Smets MJ; Baumbach-Reardon L; Young ML; Farooq A; Bishopric NH
Heart Rhythm; 2013 May; 10(5):728-37. PubMed ID: 23291057
[TBL] [Abstract][Full Text] [Related]
3. Long QT mutations at the interface between KCNQ1 helix C and KCNE1 disrupt I(KS) regulation by PKA and PIP₂.
Dvir M; Strulovich R; Sachyani D; Ben-Tal Cohen I; Haitin Y; Dessauer C; Pongs O; Kass R; Hirsch JA; Attali B
J Cell Sci; 2014 Sep; 127(Pt 18):3943-55. PubMed ID: 25037568
[TBL] [Abstract][Full Text] [Related]
4. Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
Wu X; Larsson HP
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322401
[TBL] [Abstract][Full Text] [Related]
5. Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels.
Yu H; Lin Z; Mattmann ME; Zou B; Terrenoire C; Zhang H; Wu M; McManus OB; Kass RS; Lindsley CW; Hopkins CR; Li M
Proc Natl Acad Sci U S A; 2013 May; 110(21):8732-7. PubMed ID: 23650380
[TBL] [Abstract][Full Text] [Related]
6. LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms.
Aromolaran AS; Subramanyam P; Chang DD; Kobertz WR; Colecraft HM
Cardiovasc Res; 2014 Dec; 104(3):501-11. PubMed ID: 25344363
[TBL] [Abstract][Full Text] [Related]
7. Functional interactions between KCNE1 C-terminus and the KCNQ1 channel.
Chen J; Zheng R; Melman YF; McDonald TV
PLoS One; 2009; 4(4):e5143. PubMed ID: 19340287
[TBL] [Abstract][Full Text] [Related]
8. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
[TBL] [Abstract][Full Text] [Related]
9. Functional effects of a KCNQ1 mutation associated with the long QT syndrome.
Boulet IR; Raes AL; Ottschytsch N; Snyders DJ
Cardiovasc Res; 2006 Jun; 70(3):466-74. PubMed ID: 16564513
[TBL] [Abstract][Full Text] [Related]
10. 4,4'-Diisothiocyanato-2,2'-Stilbenedisulfonic Acid (DIDS) Modulates the Activity of KCNQ1/KCNE1 Channels by an Interaction with the Central Pore Region.
Bollmann E; Schreiber JA; Ritter N; Peischard S; Ho HT; Wünsch B; Strünker T; Meuth S; Budde T; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2020 Apr; 54(2):321-332. PubMed ID: 32259418
[TBL] [Abstract][Full Text] [Related]
11. Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373).
Jow F; Tseng E; Maddox T; Shen R; Kowal D; Dunlop J; Mekonnen B; Wang K
Assay Drug Dev Technol; 2006 Aug; 4(4):443-50. PubMed ID: 16945016
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
[No Abstract] [Full Text] [Related]
13. Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure.
Watanabe E; Yasui K; Kamiya K; Yamaguchi T; Sakuma I; Honjo H; Ozaki Y; Morimoto S; Hishida H; Kodama I
Circ J; 2007 Apr; 71(4):471-8. PubMed ID: 17384445
[TBL] [Abstract][Full Text] [Related]
14. Long QT 1 mutation KCNQ1A344V increases local anesthetic sensitivity of the slowly activating delayed rectifier potassium current.
Siebrands CC; Binder S; Eckhoff U; Schmitt N; Friederich P
Anesthesiology; 2006 Sep; 105(3):511-20. PubMed ID: 16931984
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.
Shamgar L; Ma L; Schmitt N; Haitin Y; Peretz A; Wiener R; Hirsch J; Pongs O; Attali B
Circ Res; 2006 Apr; 98(8):1055-63. PubMed ID: 16556865
[TBL] [Abstract][Full Text] [Related]
16. A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.
Coyan FC; Abderemane-Ali F; Amarouch MY; Piron J; Mordel J; Nicolas CS; Steenman M; Mérot J; Marionneau C; Thomas A; Brasseur R; Baró I; Loussouarn G
PLoS One; 2014; 9(3):e93255. PubMed ID: 24681627
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits.
Zheng R; Thompson K; Obeng-Gyimah E; Alessi D; Chen J; Cheng H; McDonald TV
Biochem J; 2010 Apr; 428(1):75-84. PubMed ID: 20196769
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of disease pathogenesis in long QT syndrome type 5.
Harmer SC; Wilson AJ; Aldridge R; Tinker A
Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol-4,5-bisphosphate is required for KCNQ1/KCNE1 channel function but not anterograde trafficking.
Royal AA; Tinker A; Harmer SC
PLoS One; 2017; 12(10):e0186293. PubMed ID: 29020060
[TBL] [Abstract][Full Text] [Related]
20. Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome.
Park KH; Piron J; Dahimene S; Mérot J; Baró I; Escande D; Loussouarn G
Circ Res; 2005 Apr; 96(7):730-9. PubMed ID: 15746441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
